Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-25449

Single-particle
30.0 Å
EMD-25449 Deposition: 19/11/2021
Map released: 22/12/2021
Last modified: 17/01/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-25449

RFN_131, a Ferritin-based Nanoparticle Vaccine Candidate Displaying the SARS-CoV-2 Receptor-Binding Domain

EMD-25449

Single-particle
30.0 Å
EMD-25449 Deposition: 19/11/2021
Map released: 22/12/2021
Last modified: 17/01/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2
Sample: RFN_131, a Ferritin-based Nanoparticle Vaccine Candidate Displaying the SARS-CoV-2 Receptor-Binding Domain

Deposition Authors: Thomas PV , Smith C, Chen WH , Sankhala RS , Hajduczki A, Choe M , Martinez E , Chang W, Peterson CE , Karch C , Gohain N , Kannadka CB, de Val N , Joyce MG , Modjarrad K
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity